Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study
- Resource Type
- Source
- Diabetes, Obesity & Metabolism
- Subject
Blood Glucose medicine.medical_specialty Glycated Hemoglobin A COVID-19 Vaccines Coronavirus disease 2019 (COVID-19) COVID-19 Vaccine Endocrinology, Diabetes and Metabolism MEDLINE Type 2 diabetes Glycemic Control Affect (psychology) Endocrinology Immunogenicity, Vaccine Internal medicine Research Letter Internal Medicine medicine Humans In patient Poor glycaemic control Glycated Hemoglobin business.industry Immunogenicity COVID-19 medicine.disease Research Letters Vaccination Diabetes Mellitus, Type 2 business Human - Language
- ISSN
- 1463-1326